It’s our first innovative development, and its clinical trial is about to be launched in early September, on more than 30 healthy volunteers.
A skin cream containing the innovative peptide developped by Regentis-Pharma is about to be tested on more than 30 volunteer women with deep wrinckles. This anti-ageing product will be applied twice a day for 28 days, to prove its efficiency and its remarkable anti-ageing properties.
The results of this clinical trial will be published.
